Study Conduct

Magic Johnson—Celebrity Spokesperson for Minority Patient Recruitment?

Friday, April 18, 2008 12:18 PM

Earvin “Magic” Johnson, NBA champion and chairman and chief executive officer of the Johnson Development Corp., came to IIR’s 17th Annual Partnerships with CROs in Las Vegas, Nevada, with a mission—to urge pharma to increase minority participation in clinical trials. But, he left, quite possibly, with an even bigger mission—to become a celebrity spokesperson for minority patient recruitment.

More... »

EDICT Report Provides Road Map To Comprehensive Patient Enrollment

Monday, April 7, 2008 06:01 AM

A much anticipated report published by Baylor College’s Eliminating Disparities in Clinical Trials [EDICT] project has provided a nine-step action plan for improving the policies surrounding the conduct of clinical trials. The EDICT project set out to create a series of policy proposals designed to help patient recruitment and retention in clinical trials. The four-year project is supported by an unrestricted grant from Genentech.

More... »

EDICT Project Opens Policy Recommendations For Public Comment

Thursday, March 6, 2008 08:20 AM

The EDICT project, short for Eliminating Disparities in Clinical Trials, has invited the public to comment on a series of policy proposals design to help patient recruitment and retention in clinical trials. The period open to public comment runs until March 21.

More... »

Rapid Growth of Asia-Pacific Clinical Trials Market Focus of New CenterWatch Report

Wednesday, February 6, 2008 11:56 AM

CenterWatch, a publishing and information services company focused on market research about clinical trials, finds in a new report that the Asia-Pacific region is grabbing an increasing share of the global clinical trial market, and with new regulatory changes across the region, has already been growing at more than 50% in recent years.

More... »

Negative or Positive Trial Results?

Thursday, January 17, 2008 02:19 PM

There’s some great quotes in the Wall Street Journal’s story about the New England Journal of Medicine’s assertion that effectiveness of antidepressants has been exaggerated by selective publication of positive clinical trial results.

More... »

Dissuasion in Recruitment Research

Wednesday, January 2, 2008 11:04 AM

Of all the techniques considered for affecting the behavior of patients and encouraging their clinical trial participation, nary a single researcher has considered the benefits of dissuasion. It is true on its face the concept seems a bit counterintuitive. After all, typical recruitment approaches involve persuasion, enticement, inducement and have, during less proud times, inched closer toward undue influence. What has not yet been explored is the benefit of dissuasion, or discouraging participants from refusing to participate in voluntary clinical research.

More... »

CWWeekly November 26th 2007 Issue

Friday, November 30, 2007 10:22 AM

Top News

More... »

eClinical Technology News

Tuesday, November 20, 2007 09:06 PM

Pittsburgh, Pa.-based ePRO company invivodata launched its new version of its EPX management system: EPX ePRO Management System, Version 5.0. The system is web-based and has the capability to manage site performance, patient enrollment and compliance, and data integrity in real-time. The system can also generate user-customized reports and changeable dashboard views. It has an e-mail alert system that signals when items need action taken and boasts the industry’s only electronic data clarification form (EDCF) system to resolve discrepancies in data.

More... »

Standard Recruiting Practices in the People’s Republic of China

Wednesday, October 10, 2007 11:03 AM

By Dr. Diana Anderson, president, CEO and founder of D. L. Anderson International

More... »

BBK Creates New Global Mobilization Team Division

Tuesday, June 19, 2007 08:34 AM

Newton, Mass.-based patient recruitment company BBK Worldwide has created a new company division called the global mobilization team. The company stated that this division will help address the challenges of planning and deploying of resources for large-scale, global trials. BBK stated the division will include in-country staff with expertise in local patient recruitment, a web-based communication structure and real-time access to data essential for making changes in recruitment operations mid-trial.

More... »